1 year return (CAGR)
79.27%
Ligand Pharmaceuticals Incorporated Exchange (NASDAQ, USD)
LGND
298.50
+8.43 (+2.91%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
68.87%
5 year return (CAGR)
17.72%
10 year return (CAGR)
10.13%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
5.95B
Price/Sales
20.48
Ent value
6.16B
Price/Book
6.15
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
30.17
PEG
-
Forward P/E
25.01
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 291.00 |
| Daily high | 300.48 |
| Daily low | 289.00 |
| Daily Volume | 309K |
| All-time high | 322.61 |
| 1y analyst estimate | 342.82 |
| Beta | 0.98 |
| EPS (TTM) | 9.03 |
| Dividend per share | 0.00 |
| Ex-div date | 2 Jul 2010 |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| LGND | S&P500 | |
| Current price drop from All-time high | -7.47% | -0.58% |
| Highest price drop | -95.01% | -56.47% |
| Date of highest drop | 19 Nov 2008 | 9 Mar 2009 |
| Avg drop from high | -53.48% | -10.68% |
| Avg time to new high | 127 days | 12 days |
| Max time to new high | 4497 days | 1805 days |
News
